WHITEHAWK THERAPEUTICS, INC.
WHITEHAWK THERAPEUTICS, INC. is a registered legal entity registered in United States under 0450255274, and its current status with New Jersey Division of Revenue & Enterprise Services is active. The company was incorporated on 27 March 2018 and lists its registered address as Morristown, United States. 4 shareholders are on record for WHITEHAWK THERAPEUTICS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from New Jersey Division of Revenue & Enterprise Services and was last updated on 6 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
4
Four shareholders are currently on record for WHITEHAWK THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Vanguard Group Inc, holding 5.6% — the largest recorded stake — followed by Bridgeway Funds, Inc.-Ultra-Small Company Fund at 0.8%; the remaining 2 shareholders shown hold smaller stakes.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard Group Inc | 5.6% | New Jersey Division of Revenue & Enterprise Services | |
| Bridgeway Funds, Inc.-Ultra-Small Company Fund | 0.8% | New Jersey Division of Revenue & Enterprise Services | |
| iShares Trust-iShares Micro-Cap ETF | 0.3% | New Jersey Division of Revenue & Enterprise Services | |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 0.2% | New Jersey Division of Revenue & Enterprise Services |
Officers
5
The President, Ceo & Director of WHITEHAWK THERAPEUTICS, INC. currently on record is David J. Lennon Ph.d.; five officers are currently on record for WHITEHAWK THERAPEUTICS, INC., filed with New Jersey Division of Revenue & Enterprise Services.
The register reports 7 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at WHITEHAWK THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
WHITEHAWK THERAPEUTICS, INC. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 1 subsidiary spans United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
WHITEHAWK THERAPEUTICS, INC.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns WHITEHAWK THERAPEUTICS, INC.?
Four shareholders are currently on record for WHITEHAWK THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 5.6% — the largest recorded stake — followed by Bridgeway Funds, Inc.-Ultra-Small Company Fund at 0.8%; the remaining 2 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is WHITEHAWK THERAPEUTICS, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for WHITEHAWK THERAPEUTICS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does WHITEHAWK THERAPEUTICS, INC. have on record?
4 shareholders are shown on record for WHITEHAWK THERAPEUTICS, INC..
What is WHITEHAWK THERAPEUTICS, INC.'s company registration number?
WHITEHAWK THERAPEUTICS, INC.'s registration number is 0450255274, filed with New Jersey Division of Revenue & Enterprise Services in United States. Its current status on the register is active.
Is WHITEHAWK THERAPEUTICS, INC. still an active company?
WHITEHAWK THERAPEUTICS, INC.'s status on New Jersey Division of Revenue & Enterprise Services is listed as active.
When was WHITEHAWK THERAPEUTICS, INC. incorporated?
WHITEHAWK THERAPEUTICS, INC. was incorporated on 27 March 2018, according to New Jersey Division of Revenue & Enterprise Services.
What is WHITEHAWK THERAPEUTICS, INC.'s registered address?
The registered address on file for WHITEHAWK THERAPEUTICS, INC. is Morristown, United States.
Who are the officers/directors of WHITEHAWK THERAPEUTICS, INC.?
The President, Ceo & Director of WHITEHAWK THERAPEUTICS, INC. currently on record is David J. Lennon Ph.d.; five officers are currently on record for WHITEHAWK THERAPEUTICS, INC., filed with New Jersey Division of Revenue & Enterprise Services. Management authority at WHITEHAWK THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does WHITEHAWK THERAPEUTICS, INC. have a parent company or subsidiaries?
WHITEHAWK THERAPEUTICS, INC. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 1 jurisdiction. Those 1 subsidiary spans United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to WHITEHAWK THERAPEUTICS, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from New Jersey Division of Revenue & Enterprise Services. Zavia's monitoring API can track changes to WHITEHAWK THERAPEUTICS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access WHITEHAWK THERAPEUTICS, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like WHITEHAWK THERAPEUTICS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from New Jersey Division of Revenue & Enterprise Services and was last synced on 6 October 2026.